1152 related articles for article (PubMed ID: 24344086)
1. Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis.
Schulman S; Kakkar AK; Goldhaber SZ; Schellong S; Eriksson H; Mismetti P; Christiansen AV; Friedman J; Le Maulf F; Peter N; Kearon C;
Circulation; 2014 Feb; 129(7):764-72. PubMed ID: 24344086
[TBL] [Abstract][Full Text] [Related]
2. Management and outcomes of major bleeding during treatment with dabigatran or warfarin.
Majeed A; Hwang HG; Connolly SJ; Eikelboom JW; Ezekowitz MD; Wallentin L; Brueckmann M; Fraessdorf M; Yusuf S; Schulman S
Circulation; 2013 Nov; 128(21):2325-32. PubMed ID: 24081972
[TBL] [Abstract][Full Text] [Related]
3. Extended use of dabigatran, warfarin, or placebo in venous thromboembolism.
Schulman S; Kearon C; Kakkar AK; Schellong S; Eriksson H; Baanstra D; Kvamme AM; Friedman J; Mismetti P; Goldhaber SZ; ;
N Engl J Med; 2013 Feb; 368(8):709-18. PubMed ID: 23425163
[TBL] [Abstract][Full Text] [Related]
4. Dabigatran versus warfarin in the treatment of acute venous thromboembolism.
Schulman S; Kearon C; Kakkar AK; Mismetti P; Schellong S; Eriksson H; Baanstra D; Schnee J; Goldhaber SZ;
N Engl J Med; 2009 Dec; 361(24):2342-52. PubMed ID: 19966341
[TBL] [Abstract][Full Text] [Related]
5. Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial.
Healey JS; Eikelboom J; Douketis J; Wallentin L; Oldgren J; Yang S; Themeles E; Heidbuchel H; Avezum A; Reilly P; Connolly SJ; Yusuf S; Ezekowitz M;
Circulation; 2012 Jul; 126(3):343-8. PubMed ID: 22700854
[TBL] [Abstract][Full Text] [Related]
6. Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*). A randomised, double-blind, non-inferiority trial.
Eriksson BI; Dahl OE; Huo MH; Kurth AA; Hantel S; Hermansson K; Schnee JM; Friedman RJ;
Thromb Haemost; 2011 Apr; 105(4):721-9. PubMed ID: 21225098
[TBL] [Abstract][Full Text] [Related]
7. Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer.
Schulman S; Goldhaber SZ; Kearon C; Kakkar AK; Schellong S; Eriksson H; Hantel S; Feuring M; Kreuzer J
Thromb Haemost; 2015 Jul; 114(1):150-7. PubMed ID: 25739680
[TBL] [Abstract][Full Text] [Related]
8. Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial.
Eikelboom JW; Wallentin L; Connolly SJ; Ezekowitz M; Healey JS; Oldgren J; Yang S; Alings M; Kaatz S; Hohnloser SH; Diener HC; Franzosi MG; Huber K; Reilly P; Varrone J; Yusuf S
Circulation; 2011 May; 123(21):2363-72. PubMed ID: 21576658
[TBL] [Abstract][Full Text] [Related]
9. Bleeding events with dabigatran or warfarin in patients with venous thromboembolism.
Majeed A; Goldhaber SZ; Kakkar A; Kearon C; Eriksson H; Kreuzer J; Feuring M; Hantel S; Friedman J; Schellong S; Schulman S
Thromb Haemost; 2016 Jan; 115(2):291-8. PubMed ID: 26403199
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER®, RE-COVER™ II, and RE-MEDY™.
Goldhaber SZ; Eriksson H; Kakkar A; Schellong S; Feuring M; Fraessdorf M; Kreuzer J; Schueler E; Schulman S
Vasc Med; 2016 Dec; 21(6):506-514. PubMed ID: 27807306
[TBL] [Abstract][Full Text] [Related]
11. Dabigatran versus warfarin in patients with mechanical heart valves.
Eikelboom JW; Connolly SJ; Brueckmann M; Granger CB; Kappetein AP; Mack MJ; Blatchford J; Devenny K; Friedman J; Guiver K; Harper R; Khder Y; Lobmeyer MT; Maas H; Voigt JU; Simoons ML; Van de Werf F;
N Engl J Med; 2013 Sep; 369(13):1206-14. PubMed ID: 23991661
[TBL] [Abstract][Full Text] [Related]
12. Dabigatran versus Warfarin for Acute Venous Thromboembolism in Elderly or Impaired Renal Function Patients: Pooled Analysis of RE-COVER and RE-COVER II.
Goldhaber SZ; Schulman S; Eriksson H; Feuring M; Fraessdorf M; Kreuzer J; Schüler E; Schellong S; Kakkar A
Thromb Haemost; 2017 Nov; 117(11):2045-2052. PubMed ID: 29202209
[TBL] [Abstract][Full Text] [Related]
13. Treatment of acute pulmonary embolism after catheter-directed thrombolysis with dabigatran vs warfarin: Results of a multicenter randomized RE-SPIRE trial.
Gostev AA; Valiev E; Zeidlits GA; Shmidt EA; Osipova OS; Cheban AV; Saaya SB; Barbarash OL; Karpenko AA
J Vasc Surg Venous Lymphat Disord; 2024 Jul; 12(4):101848. PubMed ID: 38346475
[TBL] [Abstract][Full Text] [Related]
14. Balancing the benefits and risks of 2 doses of dabigatran compared with warfarin in atrial fibrillation.
Eikelboom JW; Connolly SJ; Hart RG; Wallentin L; Reilly P; Oldgren J; Yang S; Yusuf S
J Am Coll Cardiol; 2013 Sep; 62(10):900-8. PubMed ID: 23770182
[TBL] [Abstract][Full Text] [Related]
15. Bleeding events among new starters and switchers to dabigatran compared with warfarin in atrial fibrillation.
Larsen TB; Gorst-Rasmussen A; Rasmussen LH; Skjøth F; Rosenzweig M; Lip GY
Am J Med; 2014 Jul; 127(7):650-656.e5. PubMed ID: 24530792
[TBL] [Abstract][Full Text] [Related]
16. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.
Lee AYY; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Khorana AA;
JAMA; 2015 Aug; 314(7):677-686. PubMed ID: 26284719
[TBL] [Abstract][Full Text] [Related]
17. Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study.
Marijon E; Le Heuzey JY; Connolly S; Yang S; Pogue J; Brueckmann M; Eikelboom J; Themeles E; Ezekowitz M; Wallentin L; Yusuf S;
Circulation; 2013 Nov; 128(20):2192-201. PubMed ID: 24016454
[TBL] [Abstract][Full Text] [Related]
18. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.
; Büller HR; Décousus H; Grosso MA; Mercuri M; Middeldorp S; Prins MH; Raskob GE; Schellong SM; Schwocho L; Segers A; Shi M; Verhamme P; Wells P
N Engl J Med; 2013 Oct; 369(15):1406-15. PubMed ID: 23991658
[TBL] [Abstract][Full Text] [Related]
19. Direct oral anticoagulants for acute venous thromboembolism: closing the circle?
Verhamme P; Bounameaux H
Circulation; 2014 Feb; 129(7):725-7. PubMed ID: 24344085
[No Abstract] [Full Text] [Related]
20. Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.
Graham DJ; Reichman ME; Wernecke M; Zhang R; Southworth MR; Levenson M; Sheu TC; Mott K; Goulding MR; Houstoun M; MaCurdy TE; Worrall C; Kelman JA
Circulation; 2015 Jan; 131(2):157-64. PubMed ID: 25359164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
